Wednesday, November 30, 2016

SGMO: Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ

New alert via PocketInfo for SGMO:

Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ

Press Releases: http://investor.sangamo.com/releases.cfm
SEC Filings: http://investor.sangamo.com/sec.cfm
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8

No comments:

Post a Comment